Background Ebola virus is one of the most virulent pathogens, killing a ver
y high proportion of patients within 5-7 days. Two outbreaks of fulminating
haemorrhagic fever occurred in northern Gabon in 1996, with a 70% case-fat
ality rate. During both outbreaks we identified some individuals in direct
contact with sick patients who never developed symptoms. We aimed to determ
ine whether these individuals were indeed infected with Ebola virus, and ho
w they maintained asymptomatic status.
Methods Blood was collected from 24 close contacts of symptomatic patients.
These asymptomatic individuals were sampled 2, 3, or 4 times during a 1-mo
nth period after the first exposure to symptomatic patients. Serum samples
were analysed for the presence of Ebola antigens, virus-specific IgM and Ig
G (by ELISA and western blot), and different cytokines and chemokines. RNA
was extracted from peripheral blood mononuclear cells, and reverse-transcri
ptase-PCR assays were done to amplify RNA of Ebola virus. PCR products were
then sequenced.
Findings 11 of 24 asymptomatic individuals developed both IgM and IgG respo
nses to Ebola antigens, indicating viral infection. Western-blot analysis s
howed that IgG responses were directed to nucleoprotein and viral protein o
f 40 kDa. The glycoprotein and viral protein of 24 kDa genes showed no nucl
eotide differences between symptomatic and asymptomatic individuals. Asympt
omatic individuals had a strong inflammatory response characterised by high
circulating concentrations of cytokines and chemokines.
Interpretation This study showed that asymptomatic, replicative Ebola infec
tion can and does occur in human beings. The lack of genetic differences be
tween symptomatic and asymptomatic individuals suggest that asymptomatic Eb
ola infection did not result from viral mutations. Elucidation of the facto
rs related to the genesis of the strong inflammatory response occurring ear
ly during the infectious process in these asymptomatic individuals could in
crease our understanding of the disease.